AstraZeneca to invest £300m in UK in major policy-driven U-turn
The investment, revealed by Prime Minister Keir Starmer, will be directed toward two of the company’s key sites in Cambridge and Macclesfield.
Credit: motorolka-shutterstock
Pharmaceutical giant AstraZeneca has announced a £300 million investment in the United Kingdom, marking a significant reversal of its earlier decision to scale back spending in the country and signalling renewed confidence in the UK’s life sciences sector.
Register for FREE to keep reading
Join 12,000+ scientists, engineers, and IT professionals driving innovation through informatics, HPC, and simulation with:
- Insights into HPC, AI, lab informatics & data
- Curated content for life sciences, engineering & academia
- Access to Breakthroughs: real-world computing success
- Free reports & panels, including the Lab Informatics Guide
- White Papers & software updates for smarter research
Sign up now
Already a member? Log in here
Your data is protected under our privacy policy.
